Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study

Andrea Visentin; Francesca Romana Mauro; Francesca Cibien; Candida Vitale; Gianluigi Reda; Alberto Fresa; Stefania Ciolli; Daniela Pietrasanta; Monia Marchetti; Roberta Murru; Massimo Gentile; Gian Matteo Rigolin; Francesca Maria Quaglia; Lydia Scarfò; Paolo Sportoletti; Stefano Pravato; Francesco Piazza; Marta Coscia; Luca Laurenti; Stefano Molica; Robin Foà; Antonio Cuneo; Livio Trentin

doi:10.1002/ajh.26437

Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study

Andrea Visentin, Francesca Romana Mauro, Francesca Cibien, Candida Vitale, Gianluigi Reda, Alberto Fresa, Stefania Ciolli, Daniela Pietrasanta, Monia Marchetti, Roberta Murru, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Lydia Scarfò, Paolo Sportoletti, Stefano Pravato, Francesco Piazza, Marta Coscia, Luca Laurenti, Stefano MolicaRobin Foà, Antonio Cuneo, Livio Trentin

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

NA

Lingua originale	English
pagine (da-a)	E95-E99
Rivista	American Journal of Hematology
Volume	97
DOI	https://doi.org/10.1002/ajh.26437
Stato di pubblicazione	Pubblicato - 2022

Keywords

Ibrutinib

Accesso al documento

10.1002/ajh.26437

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Visentin, A., Mauro, F. R., Cibien, F., Vitale, C., Reda, G., Fresa, A., Ciolli, S., Pietrasanta, D., Marchetti, M., Murru, R., Gentile, M., Rigolin, G. M., Quaglia, F. M., Scarfò, L., Sportoletti, P., Pravato, S., Piazza, F., Coscia, M., Laurenti, L., ... Trentin, L. (2022). Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study. American Journal of Hematology, 97, E95-E99. https://doi.org/10.1002/ajh.26437

@article{04b3ac92863245478c85b89f46f71c54,

title = "Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study",

abstract = "NA",

keywords = "Ibrutinib, Ibrutinib",

author = "Andrea Visentin and Mauro, {Francesca Romana} and Francesca Cibien and Candida Vitale and Gianluigi Reda and Alberto Fresa and Stefania Ciolli and Daniela Pietrasanta and Monia Marchetti and Roberta Murru and Massimo Gentile and Rigolin, {Gian Matteo} and Quaglia, {Francesca Maria} and Lydia Scarf{\`o} and Paolo Sportoletti and Stefano Pravato and Francesco Piazza and Marta Coscia and Luca Laurenti and Stefano Molica and Robin Fo{\`a} and Antonio Cuneo and Livio Trentin",

year = "2022",

doi = "10.1002/ajh.26437",

language = "English",

volume = "97",

pages = "E95--E99",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

}

Visentin, A, Mauro, FR, Cibien, F, Vitale, C, Reda, G, Fresa, A, Ciolli, S, Pietrasanta, D, Marchetti, M, Murru, R, Gentile, M, Rigolin, GM, Quaglia, FM, Scarfò, L, Sportoletti, P, Pravato, S, Piazza, F, Coscia, M, Laurenti, L, Molica, S, Foà, R, Cuneo, A & Trentin, L 2022, 'Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study', American Journal of Hematology, vol. 97, pagg. E95-E99. https://doi.org/10.1002/ajh.26437

TY - JOUR

T1 - Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study

AU - Visentin, Andrea

AU - Mauro, Francesca Romana

AU - Cibien, Francesca

AU - Vitale, Candida

AU - Reda, Gianluigi

AU - Fresa, Alberto

AU - Ciolli, Stefania

AU - Pietrasanta, Daniela

AU - Marchetti, Monia

AU - Murru, Roberta

AU - Gentile, Massimo

AU - Rigolin, Gian Matteo

AU - Quaglia, Francesca Maria

AU - Scarfò, Lydia

AU - Sportoletti, Paolo

AU - Pravato, Stefano

AU - Piazza, Francesco

AU - Coscia, Marta

AU - Laurenti, Luca

AU - Molica, Stefano

AU - Foà, Robin

AU - Cuneo, Antonio

AU - Trentin, Livio

PY - 2022

Y1 - 2022

N2 - NA

AB - NA

KW - Ibrutinib

UR - http://hdl.handle.net/10807/235490

U2 - 10.1002/ajh.26437

DO - 10.1002/ajh.26437

M3 - Article

SN - 0361-8609

VL - 97

SP - E95-E99

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -

Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo